EPIX Pharmaceuticals, Inc. - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for EPIX Pharmaceuticals, Inc.. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

EPIX Pharmaceuticals, Inc.. The Group's principal activity is to discovers, develops and commercializes novel pharmaceutical products to better diagnose, treat and manage patients. The Group have four therapeutic product candidates in clinical trials targeting conditions such as depression, Alzheimer's disease, cardiovascular disease and obesity in addition, two imaging agents in various stages of clinical development. Its blood-pool imaging agent (Vasovist) is approved in the European Union, Canada, Iceland, Norway, Switzerland and Australia, and is currently marketed in the Netherlands, Norway, Sweden, Denmark, United Kingdom, Austria and Germany.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report